Narayanaswamy Super Speciality Hospitals Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 4.99 Cr
as on 24-10-2024
- Company Age 13 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 7.55 Cr
as on 24-10-2024
- Revenue -48.81%
(FY 2023)
- Profit -45.48%
(FY 2023)
- Ebitda -25.77%
(FY 2023)
- Net Worth 11.97%
(FY 2023)
- Total Assets -10.49%
(FY 2023)
About Narayanaswamy Super Speciality Hospitals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 4.99 Cr.
The company has closed loans amounting to ₹7.55 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Venkatappa Narayanaswamy and Uma Kesaragere serve as directors at the Company.
- CIN/LLPIN
U85110KA2011PTC059449
- Company No.
059449
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Jul 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Social Media-
Who are the key members and board of directors at Narayanaswamy Super Speciality Hospitals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkatappa Narayanaswamy  | Director | 04-Jul-2011 | Current |
| Uma Kesaragere | Director | 25-Aug-2011 | Current |
Financial Performance of Narayanaswamy Super Speciality Hospitals.
Narayanaswamy Super Speciality Hospitals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 48.81% decrease. The company also saw a substantial fall in profitability, with a 45.48% decrease in profit. The company's net worth Soared by an impressive increase of 11.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Narayanaswamy Super Speciality Hospitals?
In 2023, Narayanaswamy Super Speciality Hospitals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vagus Super Speciality Hospital Private LimitedActive 18 years 8 monthsVenkatappa Narayanaswamy and Uma Kesaragere are mutual person
- Jeera Sannidhi Medical And Research Centre Private LimitedActive 5 years 4 months
Uma Kesaragere is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 05 Mar 2012 | ₹7.55 Cr | Satisfied |
How Many Employees Work at Narayanaswamy Super Speciality Hospitals?
Unlock and access historical data on people associated with Narayanaswamy Super Speciality Hospitals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Narayanaswamy Super Speciality Hospitals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Narayanaswamy Super Speciality Hospitals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
